Companies: 10,795·Total market cap: $144.5T
Sionna Therapeutics, Inc.

Sionna Therapeutics, Inc.

SIONNASDAQHealthcare● Active
$33.55
$-1.82(-5.16%)
Market Cap$1.5B
P/E Ratio
52W High$48.445
52W Low$13.51

Sionna Therapeutics, Inc. (SION) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

sion · stock forecast · 7 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 7 Wall Street analysts in the past 3 months

SellBuy

Buy

7 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
5
Hold
1
Sell
1
Strong Sell
0
Total: 7 · Buy rate: 71.4%

12-Month Price Target

High

$58.00

Consensus

$54.00

+65.0% upside

Low

$50.00

Median: $54 · Last Close: $32.72

The Sionna Therapeutics, Inc. (SION) analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month SION price target is $54.00, representing +65.0% upside from the current price of $32.72.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $54 (65.0%)

Consensus Target

$54.00

65.0% upside

High Target

$58

77.2%

Low Target

$50

52.8%

Current Price

$32.72

as of today

Based on analyst price targets, the SION stock price prediction for the next 12 months ranges from $50 to $58. The consensus SION price forecast of $54.00 implies 65.0% upside from the current price of $32.72.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$31.095.00%

1-day model range: $30.82–$31.35. Peak: $31.35 (-5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$43+30.0%
2028$50+51.4%
2029$54+65.1%
2030$57+73.4%
2031+78.1%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)35.1Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · SION · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$35.81SELL
MA 10$39.19SELL
MA 20$40.21SELL
MA 50$40.32SELL
MA 100$39.22SELL
MA 200$36.77SELL
Current $SION · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$35.92SELL
EMA 10$37.77SELL
EMA 20$39.20SELL
EMA 50$39.72SELL
EMA 100$38.89SELL
EMA 200$34.66SELL
Current $SION · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Citizens2026-05-26
Maintains
Market OutperformMarket Outperform
Freedom Broker2026-05-20
Downgrade ↓
BuyHold
Stifel2026-05-18
Maintains
BuyBuy
BTIG2026-05-13
Maintains
BuyBuy
Jones Trading2026-04-28
Maintains
BuyBuy
BTIG2026-04-27
Maintains
BuyBuy
Guggenheim2026-03-03
Maintains
BuyBuy
BTIG2026-03-02
Maintains
BuyBuy
BTIG2026-01-14
Maintains
BuyBuy
BTIG2026-01-07
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Sionna Therapeutics, Inc. (SION) stock. Of the recent 11 rating actions, 0 were upgrades and 2 were downgrades. 7 analysts currently cover SION.

Analyst Recommendation Trends

Buy ratings03↑ +3
Hold ratings01↑ +1
Sell ratings101

SION analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 3 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$0M

↓ 100.0% YoY

Revenue Next Year

$3M

EPS This Year

$-2.58

EPS Next Year

$-2.83

↑ 9.9% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast SION EPS of $-2.58 for the current fiscal year, based on estimates from 7 analysts. The SION revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The SION stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SION price target is $54.00 (+65.0% upside), with an analyst consensus of Buy.

The SION short-term stock prediction for tomorrow is $31.09 (-5.00%). The SION stock price prediction for 2027 estimates an average of $43. The SION stock prediction for 2030 projects a range of $51–$62.

Sionna Therapeutics, Inc. trades on NASDAQ under the ticker SION. The SION stock outlook for 2027 is broadly positive, supported by a Buy consensus among 71% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

SION forecast · 8 questions

According to 7 Wall Street analysts, the average 12-month SION price target is $54.00, with a high forecast of $58.00 and a low of $50.00. The median price target is shown in the chart above when available. This implies +65.0% potential upside from the current price of $32.72.

SION price targetWhat is SION price targetSION analyst price targetSION 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.